Variant report

Variant	esv3415576
Chromosome Location	chr6:150920109-150923107
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr6:150921705-150922322	GM12878	blood:	n/a	n/a
2	BACH1	chr6:150921699-150921830	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr6:150920260-150920552	GM12878	blood:	n/a	n/a
4	BCL11A	chr6:150920350-150920669	GM12878	blood:	n/a	chr6:150920568-150920577
5	BCLAF1	chr6:150921780-150922253	GM12878	blood:	n/a	chr6:150921830-150921843
6	BHLHE40	chr6:150920401-150921055	GM12878	blood:	n/a	n/a
7	BHLHE40	chr6:150921560-150922256	GM12878	blood:	n/a	chr6:150922071-150922087
8	BRCA1	chr6:150922271-150922292	H1-hESC	embryonic stem cell:	n/a	n/a
9	BRCA1	chr6:150921906-150922070	H1-hESC	embryonic stem cell:	n/a	n/a
10	CCNT2	chr6:150920983-150921162	K562	blood:	n/a	n/a
11	CEBPB	chr6:150921962-150922157	HepG2	liver:	n/a	n/a
12	CEBPB	chr6:150922045-150922142	IMR90	lung:	n/a	n/a
13	CEBPB	chr6:150921877-150922132	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr6:150921556-150922280	GM12878	blood:	n/a	n/a
15	CHD2	chr6:150921813-150922242	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr6:150921600-150921750	GM12874	blood:	n/a	n/a
17	CTCF	chr6:150922000-150922150	GM12874	blood:	n/a	chr6:150922070-150922083
18	CTCF	chr6:150921940-150922090	GM12872	blood:	n/a	chr6:150922070-150922083
19	CTCF	chr6:150922000-150922150	AG09309	skin:	n/a	chr6:150922070-150922083
20	CTCF	chr6:150922040-150922190	GM12864	blood:	n/a	chr6:150922070-150922083
21	CTCF	chr6:150921980-150922130	NB4	blood:	n/a	chr6:150922070-150922083
22	CTCF	chr6:150921940-150922090	GM12867	blood:	n/a	chr6:150922070-150922083
23	CTCF	chr6:150921980-150922130	BJ	skin:	n/a	chr6:150922070-150922083
24	CTCF	chr6:150921960-150922110	GM12873	blood:	n/a	chr6:150922070-150922083
25	CTCF	chr6:150921924-150922178	Fibrobl	skin:	n/a	chr6:150922070-150922083
26	CTCF	chr6:150921700-150921850	GM12865	blood:	n/a	n/a
27	CTCF	chr6:150922024-150922109	GM20000	blood:	n/a	chr6:150922070-150922083
28	CTCF	chr6:150921980-150922130	HUVEC	blood vessel:	n/a	chr6:150922070-150922083
29	CTCF	chr6:150922000-150922150	MCF-7	breast:	n/a	chr6:150922070-150922083
30	CTCF	chr6:150921893-150922189	K562	blood:	n/a	chr6:150922070-150922083
31	CTCF	chr6:150921060-150921210	HMEC	breast:	n/a	n/a
32	CTCF	chr6:150921954-150922153	Lung_OC	lung:	n/a	chr6:150922070-150922083
33	CTCF	chr6:150921942-150922181	Gliobla	brain:	n/a	chr6:150922070-150922083
34	CTCF	chr6:150921956-150922169	MCF-7	breast:	n/a	chr6:150922070-150922083
35	CTCF	chr6:150921900-150922050	HPF	lung:	n/a	n/a
36	CTCF	chr6:150921980-150922130	GM12865	blood:	n/a	chr6:150922070-150922083
37	CTCF	chr6:150921774-150922327	MCF-7	breast:	n/a	chr6:150922070-150922083
38	CTCF	chr6:150922000-150922150	AoAF	blood vessel:	n/a	chr6:150922070-150922083
39	CTCF	chr6:150921960-150922110	GM12870	blood:	n/a	chr6:150922070-150922083
40	CTCF	chr6:150921693-150921711	Kidney_OC	kidney:	n/a	n/a
41	CTCF	chr6:150921960-150922110	AG09319	gingival:	n/a	chr6:150922070-150922083
42	CTCF	chr6:150921940-150922090	WERI-Rb-1	eye:	n/a	chr6:150922070-150922083
43	CTCF	chr6:150921980-150922130	NHLF	lung:	n/a	chr6:150922070-150922083
44	CTCF	chr6:150921691-150921773	Lung_OC	lung:	n/a	n/a
45	CTCF	chr6:150921960-150922110	HFF-Myc	foreskin:	n/a	chr6:150922070-150922083
46	CTCF	chr6:150921540-150921690	GM12870	blood:	n/a	n/a
47	CTCF	chr6:150922000-150922150	HA-sp	spinal cord:	n/a	chr6:150922070-150922083
48	CTCF	chr6:150921980-150922130	Caco-2	colon:	n/a	chr6:150922070-150922083
49	CTCF	chr6:150921970-150922181	GM12891	blood:	n/a	chr6:150922070-150922083
50	CTCF	chr6:150921960-150922110	A549	lung:	n/a	chr6:150922070-150922083

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:150921569-150921619	AG10803	skin:	n/a
2	chr6:150922227-150922277	GM12878	blood:	n/a
3	chr6:150920859-150920909	HCF	heart:	n/a
4	chr6:150920859-150920909	GM06990	blood:	n/a
5	chr6:150922145-150922195	GM12878	blood:	n/a
6	chr6:150922145-150922195	HNPCEpiC	eye:	n/a
7	chr6:150921569-150921619	AG09319	gingival:	n/a
8	chr6:150922513-150922563	HPAEpiC	pulmonary alveolar:	n/a
9	chr6:150921355-150921405	AG09309	skin:	n/a
10	chr6:150920859-150920909	ProgFib	skin:	n/a
11	chr6:150922227-150922277	SK-N-MC	brain:	n/a
12	chr6:150922513-150922563	NH-A	brain:	n/a
13	chr6:150920485-150920535	PFSK-1	brain:	n/a
14	chr6:150922513-150922563	CMK	blood:	n/a
15	chr6:150920859-150920909	AG04450	lung:	fetal
16	chr6:150922227-150922277	HEK293	kidney:	embryo
17	chr6:150920485-150920535	SAEC	small airway:	n/a
18	chr6:150921355-150921405	MCF10A-Er-Src	breast:	n/a
19	chr6:150922145-150922195	ECC-1	luminal epithelium:	n/a
20	chr6:150921355-150921405	HAEpiC	amniotic membrane:	n/a
21	chr6:150920533-150920583	HIPEpiC	eye:	n/a
22	chr6:150921355-150921405	HMEC	breast:	n/a
23	chr6:150922513-150922563	Hepatocyte	liver:	n/a
24	chr6:150920859-150920909	K562	blood:	n/a
25	chr6:150921569-150921619	SK-N-SH	brain:	n/a
26	chr6:150922513-150922563	GM19239	blood:	n/a
27	chr6:150921355-150921405	Hela-S3	cervix:	n/a
28	chr6:150921569-150921619	GM06990	blood:	n/a
29	chr6:150921355-150921405	NHBE	bronchial:	n/a
30	chr6:150921569-150921619	NH-A	brain:	n/a
31	chr6:150920223-150920273	H1-hESC	embryonic stem cell:	embryo
32	chr6:150920533-150920583	HepG2	liver:	n/a
33	chr6:150920485-150920535	Hepatocyte	liver:	n/a
34	chr6:150922227-150922277	HepG2	liver:	n/a
35	chr6:150920859-150920909	HRPEpiC	eye:	n/a
36	chr6:150922513-150922563	HMEC	breast:	n/a
37	chr6:150922513-150922563	ProgFib	skin:	n/a
38	chr6:150921355-150921405	PANC-1	pancreas:	n/a
39	chr6:150920485-150920535	HRE	kidney:	n/a
40	chr6:150920859-150920909	SAEC	small airway:	n/a
41	chr6:150920223-150920273	HEK293	kidney:	embryo
42	chr6:150922145-150922195	AG04450	lung:	fetal
43	chr6:150922145-150922195	GM12891	blood:	n/a
44	chr6:150920485-150920535	AoSMC	blood vessel:	n/a
45	chr6:150920485-150920535	GM12891	blood:	n/a
46	chr6:150921355-150921405	AG04450	lung:	fetal
47	chr6:150922513-150922563	GM12878	blood:	n/a
48	chr6:150920485-150920535	SKMC	muscle:	n/a
49	chr6:150920533-150920583	Caco-2	colon:	n/a
50	chr6:150921355-150921405	HL-60	blood:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:150914794..150917748-chr6:150922118..150924160,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IYD-1	chr6:150921970-150922019	ENSG00000232891.1

Variant related genes	Relation type
ENSG00000232891	TF binding region
PLEKHG1	TF binding region
ENSG00000232891	CpG island
PLEKHG1	CpG island

Extended variants
information (count: 112 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149460785	chr6:150920129-150920130	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs530916838	chr6:150920139-150920140	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs531456229	chr6:150920152-150920153	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs569350655	chr6:150920153-150920154	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs568683689	chr6:150920158-150920159	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs144308823	chr6:150920197-150920198	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs574988011	chr6:150920260-150920261	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
8	rs200162824	chr6:150920291-150920292	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs143903288	chr6:150920294-150920295	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs186600726	chr6:150920325-150920326	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs139865193	chr6:150920337-150920338	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs546923510	chr6:150920360-150920361	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs565189594	chr6:150920383-150920384	Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs536095043	chr6:150920409-150920410	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs529147975	chr6:150920419-150920420	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs373705969	chr6:150920485-150920486	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs555674472	chr6:150920506-150920507	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs569395809	chr6:150920520-150920521	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
19	rs143297327	chr6:150920533-150920534	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
20	rs192389401	chr6:150920587-150920588	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs7759373	chr6:150920597-150920598	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs183078544	chr6:150920598-150920599	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs533744685	chr6:150920666-150920667	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs554154244	chr6:150920671-150920672	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs573971109	chr6:150920687-150920688	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs542865071	chr6:150920691-150920692	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs115739547	chr6:150920707-150920708	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs186691982	chr6:150920721-150920722	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs529853826	chr6:150920732-150920733	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs553247230	chr6:150920758-150920759	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs73008090	chr6:150920770-150920771	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs564225705	chr6:150920779-150920780	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs373168581	chr6:150920781-150920782	Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs374626252	chr6:150920802-150920803	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs533183864	chr6:150920812-150920813	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs529374324	chr6:150920843-150920844	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs546588307	chr6:150920865-150920866	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
38	rs12525982	chr6:150920882-150920883	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
39	rs529572107	chr6:150920901-150920902	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
40	rs146720600	chr6:150920913-150920914	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs569376402	chr6:150920935-150920936	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs13211067	chr6:150920945-150920946	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs532476146	chr6:150920958-150920959	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs12110435	chr6:150920965-150920966	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs538403011	chr6:150921000-150921001	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs551526351	chr6:150921148-150921149	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs571358967	chr6:150921233-150921234	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs533809902	chr6:150921254-150921255	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs553811315	chr6:150921255-150921256	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs573532591	chr6:150921292-150921293	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD

Chromatin state (count:429 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150901600-150920400	Weak transcription	Right Atrium	heart
2	chr6:150911800-150920800	Weak transcription	Aorta	Aorta
3	chr6:150916400-150920200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
4	chr6:150917200-150920200	Enhancers	Rectal Mucosa Donor 31	rectum
5	chr6:150917400-150920200	Weak transcription	Small Intestine	intestine
6	chr6:150918000-150920200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr6:150918200-150920600	Enhancers	Sigmoid Colon	Sigmoid Colon
8	chr6:150918400-150920800	Weak transcription	Psoas Muscle	Psoas
9	chr6:150918600-150920200	Enhancers	Primary B cells from peripheral blood	blood
10	chr6:150919200-150920600	Bivalent Enhancer	Fetal Intestine Large	intestine
11	chr6:150919200-150921000	Weak transcription	Spleen	Spleen
12	chr6:150919800-150920200	Enhancers	Primary T helper cells PMA-I stimulated	--
13	chr6:150919800-150920200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
14	chr6:150920000-150920200	Enhancers	Primary T helper naive cells from peripheral blood	blood
15	chr6:150920000-150920200	Bivalent/Poised TSS	Primary T regulatory cells fromperipheralblood	blood
16	chr6:150920000-150920200	Enhancers	Colonic Mucosa	Colon
17	chr6:150920000-150920200	Enhancers	Fetal Intestine Small	intestine
18	chr6:150920000-150920200	Flanking Active TSS	Fetal Kidney	kidney
19	chr6:150920000-150920200	Enhancers	Gastric	stomach
20	chr6:150920000-150920400	Flanking Active TSS	Primary B cells from cord blood	blood
21	chr6:150920000-150920400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
22	chr6:150920000-150920400	Enhancers	Primary T helper cells fromperipheralblood	blood
23	chr6:150920000-150920400	Flanking Active TSS	Liver	Liver
24	chr6:150920000-150920400	Flanking Active TSS	Duodenum Mucosa	Duodenum
25	chr6:150920000-150920400	Enhancers	Fetal Brain Female	brain
26	chr6:150920000-150920400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
27	chr6:150920000-150920400	Flanking Active TSS	Thymus	Thymus
28	chr6:150920000-150920600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr6:150920000-150920600	Flanking Active TSS	Fetal Thymus	thymus
30	chr6:150920000-150920600	Flanking Bivalent TSS/Enh	GM12878-XiMat	blood
31	chr6:150920200-150920400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr6:150920200-150920400	Bivalent Enhancer	Primary T cells from cord blood	blood
33	chr6:150920200-150920400	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
34	chr6:150920200-150920400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
35	chr6:150920200-150920400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
36	chr6:150920200-150920400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
37	chr6:150920200-150920400	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
38	chr6:150920200-150920400	Flanking Bivalent TSS/Enh	Primary Natural Killer cells fromperipheralblood	blood
39	chr6:150920200-150920400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
40	chr6:150920200-150920400	Flanking Bivalent TSS/Enh	Primary T killer memory cells from peripheral blood	blood
41	chr6:150920200-150920400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr6:150920200-150920400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr6:150920200-150920400	Enhancers	Adipose Nuclei	Adipose
44	chr6:150920200-150920400	Bivalent Enhancer	Fetal Muscle Leg	muscle
45	chr6:150920200-150920400	Enhancers	Placenta	Placenta
46	chr6:150920200-150920400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
47	chr6:150920200-150920400	Enhancers	Small Intestine	intestine
48	chr6:150920200-150920400	Enhancers	HMEC	breast
49	chr6:150920200-150920600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr6:150920200-150920600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links